Brief: Morris C. Laster - Urges Scopus Stockholders To Vote On Blue Proxy Card "For" Election Of Director Nominees, Mordechai Saar Hacham And Joshua Levine
06/12/2021 13:04
Dec 6 (Reuters) - Scopus Biopharma Inc SCPS.O :
* MORRIS C. LASTER ISSUES AN OPEN LETTER TO SCOPUS BIOPHARMA
INC.
STOCKHOLDERS IN CONNECTION WITH UPCOMING ANNUAL MEETING
* MORRIS C. LASTER - URGES SCOPUS STOCKHOLDERS TO VOTE ON
BLUE
PROXY CARD "FOR" ELECTION OF DIRECTOR NOMINEES, MORDECHAI SAAR
HACHAM AND JOSHUA LEVINE
Source text for Eikon: ID:nPn8l6C35a
Further company coverage: SCPS.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Scopus Biopharma
See all newsBrief: Scopus Biopharma - Nasdaq Hearings Panel Informed Company, By Letter Dated December 15, Of Its Determination To Delist Co's Common Stock From Nasdaq
Brief: Scopus Biopharma Completes Recapitalization To Enhance Shareholder Value
Brief: Scopus Biopharma Says Received Additional Non-Compliance Letter From Nasdaq
Brief: Scopus Biopharma Received Deficiency Letter From Nasdaq
Brief: Scopus BioPharma Inc- On April 4, Received Deficiency Notification Letter From Nasdaq Indicating Co Was Not In Compliance With Nasdaq Listing Rule